Cheng-Long Gao, Jinqian Song, Haojie Wang, Qinghong Shang, Xin Guan, Gang Xu, Jiayang Wu, Dalei Wu, Yueqin Zheng, Xudong Wu, Feng Zhao, Xindong Liu, Lei Shi, Tao Pang. The PGAM5-NEK7 interaction is a therapeutic target for NLRP3 inflammasome activation in colitisJ. Acta Pharmaceutica Sinica B, 2025, 15(1): 349-370. DOI: 10.1016/j.apsb.2024.11.019
|
Citation:
|
Cheng-Long Gao, Jinqian Song, Haojie Wang, Qinghong Shang, Xin Guan, Gang Xu, Jiayang Wu, Dalei Wu, Yueqin Zheng, Xudong Wu, Feng Zhao, Xindong Liu, Lei Shi, Tao Pang. The PGAM5-NEK7 interaction is a therapeutic target for NLRP3 inflammasome activation in colitisJ. Acta Pharmaceutica Sinica B, 2025, 15(1): 349-370. DOI: 10.1016/j.apsb.2024.11.019
|
Cheng-Long Gao, Jinqian Song, Haojie Wang, Qinghong Shang, Xin Guan, Gang Xu, Jiayang Wu, Dalei Wu, Yueqin Zheng, Xudong Wu, Feng Zhao, Xindong Liu, Lei Shi, Tao Pang. The PGAM5-NEK7 interaction is a therapeutic target for NLRP3 inflammasome activation in colitisJ. Acta Pharmaceutica Sinica B, 2025, 15(1): 349-370. DOI: 10.1016/j.apsb.2024.11.019
|
Citation:
|
Cheng-Long Gao, Jinqian Song, Haojie Wang, Qinghong Shang, Xin Guan, Gang Xu, Jiayang Wu, Dalei Wu, Yueqin Zheng, Xudong Wu, Feng Zhao, Xindong Liu, Lei Shi, Tao Pang. The PGAM5-NEK7 interaction is a therapeutic target for NLRP3 inflammasome activation in colitisJ. Acta Pharmaceutica Sinica B, 2025, 15(1): 349-370. DOI: 10.1016/j.apsb.2024.11.019
|